ZBH stock: buy or sell?
February 21st, 2020
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Should I buy ZBH stock?Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, 2 buy setups work for Zimmer Biomet stock right now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Zimmer Biomet stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for ZBH stock for the last month.
ZBH stock analysis
After marking all time highs on Wednesday, Zimmer Biomet decreased -0.63% on Feb 21st to $157.39.
After climbing to all-time highs several times in past weeks, Zimmer Biomet decreased -0.63% to $157.39. From a daily perspective, ZBH is in a short term uptrend after plotting its last bottom ($155.15, on February/10) higher than the previous bottom, and its last top ($161.11, on Wednesday) also over the previous top. Now trading in between its last bottom and last top ZBH might consolidate in a plain range, waiting to break out over $161.11 or down under $155.15. On Wednesday, ZBH hit a new all time high, pushing higher than on Feb/14 tops. Check different trading setups that use ATHs as triggers. Since Feb/3 when ZBH stock price broke up the SMA50d line, it gained $9.49 (6.42%).
Shares of Zimmer Biomet closed this week at $157.39 after topping to a new all time high ($161.11) even it couldn't close with gains and depreciated a tragic -1.88%. Early February ZBH rocketed a cool 5.43% in just one week.
ZBH shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom late January, ZBH climbed unceasignly breaking out to new all time highs. By mid June 2019 ZBH price bounced up over the SMA of 40 weeks that acted as support stopping new slides. By mid May 2019, SMA20w and SMA40w crossed up triggering a rise of 29.74%.
ZBH stock price history
ZBH stock went public on July 25th, 2001 with a price of $27.441. Since then, ZBH stock grew a 473.60%, with a yearly average of 26.30%. If you had invested $1,000 in ZBH stock in 2001, it would worth $4,736.00 today.
1: Adjusted price after possible price splits or reverse-splits.
ZBH stock historical price chart
ZBH stock reached all-time highs on Wednesday with a price of $161.11.
ZBH stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' ZBH stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price target for Zimmer Biomet stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on April, Zimmer Biomet . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual turnover report draw a slightly good growth of 1.66% to $7,932.90 million dollars. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) collapsed a -28.02% to -4.78%. To have an updated view of the financial situation of Zimmer Biomet, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Zimmer Biomet TTM sales up to March 2019 were $7,890.80 and income was $-307.80 M USD. If we compare this TTM figures with the last reported annuality, we can esteem Zimmer Biomet business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, stayed steady a tight -0.53%. In line, profit margin (net income/sales) remained stable at -4.78%.
|2013||$4,620 M||-||$761 M16.5%||-|
|2014||$4,673 M||1.15%||$720 M15.4%||-5.37%|
|2015||$5,998 M||28.34%||$147 M2.5%||-79.59%|
|2016||$7,684 M||28.11%||$306 M4.0%||108.10%|
|2017||$7,803 M||1.55%||$1,814 M23.2%||492.94%|
|2018||$7,933 M||1.66%||$-379.20 M-4.8%||-120.91%|
|TTM||$7,891 M||-0.53%||$-307.80 M-3.9%||-18.83%|
Quarterly financial resultsZimmer Biomet reported $1,975.50 M in sales for 2019-Q1, a -4.61% less compared to previous quarter. Reported quarter earnings marked $246.10 M with a profit margin of 12.46%. Profit margin boosted a 55.97% compared to previous quarter when profit margin was -43.51%. When comparing revenues to same quarter last year, Zimmer Biomet sales marked a bad loss and declined a -2.09%.
|2017-Q2||$1,950 M||-||$184.20 M9.4%||-|
|2017-Q3||$1,820 M||-6.67%||$98.80 M5.4%||-46.36%|
|2017-Q4||$2,089 M||14.79%||$1,231.40 M58.9%||1,146.36%|
|2018-Q1||$2,018 M||-3.42%||$174.70 M8.7%||-85.81%|
|2018-Q2||$2,008 M||-0.50%||$185.00 M9.2%||5.90%|
|2018-Q3||$1,837 M||-8.51%||$162.20 M8.8%||-12.32%|
|2018-Q4||$2,071 M||12.76%||$-901.10 M-43.5%||-655.55%|
|2019-Q1||$1,976 M||-4.61%||$246.10 M12.5%||-127.31%|
Zimmer Biomet ownershipWhen you are planning to buy shares of a company, it's always worth to check its ownership structure.
Zimmer Biomet shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.17% of all shares.
Bearish positions for ZBH stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related companies:
|Market cap||$32.4 B|
|Total shares||205.7 M|
|Float shares||205.6 M|
|- Institutional holdings (%)||91.8%|
|- Insider holdings (%)||0.2%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$155.98 - $159.10|
|Average true range||$3.26|
|50d mov avg||$151.46|
|100d mov avg||$145.62|
|200d mov avg||$136.20|
Zimmer Biomet performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Zimmer Biomet, the comparison is made against .
Zimmer Biomet competitorsUnfortunately, we could not find any public company that could be defined as Zimmer Biomet competitor. This doesn't mean Zimmer Biomet does not have any competitor in the market, it's just we could not detected it.
Latest ZBH stock news
- Seeking AlphaZimmer Biomet Holdings: Management Expects Modest GrowthMarch 22, 2019